Stanescu, Sinziana http://orcid.org/0000-0003-0340-4580
Belanger-Quintana, Amaya
Fernandez-Felix, Borja Manuel
Arrieta, Francisco
Quintero, Victor
Maldonado, Maria Soledad
Alcaide, Patricia
Martínez-Pardo, Mercedes
Funding for this research was provided by:
Fundación Ramón Areces (CIVP17A2827)
Article History
Received: 20 January 2021
Accepted: 10 May 2021
First Online: 18 May 2021
Declarations
:
: The study was approved by the Ethical Committee of our hospital (Hospital Universitario Ramon y Cajal, Madrid, Spain). Patients or their parents signed an informed consent prior to the inclusion in the study.
: Informed consent to participate in the study was obtained from participants or their parent or legal guardian in the case of children under 16.
: SS has received travel and speaker fees from Nutricia, Mead Johnson, Genzyme, Recordatti Rare Diseases, Vitaflo-Nestlé, BioMarin. ABQ has received travel and speaker fees from Nutricia, Mead Johnson, Genzyme, Recordatti Rare Diseases, Vitaflo-Nestlé, Takeda, BioMarin; advisory fees from BioMarin and Merk Serono. BMFF declares that she has no conflict of interest. VQ declares that he has no conflict of interest. FA has received travel and speaker fees from Nutricia, Mead Johnson, Recordatti Rare Diseases, Vitaflo-Nestlé, BioMarin. PA declares that she has no conflict of interest. MSM declares that she has no conflict of interest. MMP has received travel and speaker fees from Nutricia, Mead Johnson, Genzyme, Recordatti Rare Diseases, Vitaflo-Nestlé, Takeda, BioMarin.